A new bioassay for measuring the strength of IL-6/STAT3 signal inhibition by tocilizumab in patients with rheumatoid arthritis
Crossref DOI link: https://doi.org/10.1186/s13075-017-1434-6
Published Online: 2017-10-17
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Saito, Shuntaro
Suzuki, Katsuya
Yoshimoto, Keiko
Kaneko, Yuko
Matsumoto, Yoshihiro
Yamaoka, Kunihiro
Takeuchi, Tsutomu